eseoulpost
DomesticHealth
Seoul revokes license for gene therapy drug Invossa
min  |  min
폰트키우기 폰트줄이기 프린트하기 메일보내기 신고하기
승인 2019.05.29  
트위터 페이스북 미투데이 요즘 네이버 구글 msn
   
 

By Lee Joon-seung

 SEOUL, May 28 (Yonhap) -- South Korea's drug authorities on Tuesday canceled the license for the gene therapy drug Invossa for the mislabeling and the false reporting of an ingredient used, sending a shock to patients and the country's pharmaceuticals sector.

 The Ministry of Food and Drug Safety's move came after the manufacturer, Kolon Life Science, acknowledged that a substance in the joint pain treatment drug has been mislabeled since 2003, but failed to clearly explain why it had occurred.

 "Kolon Life Science falsely reported ingredients used, intentionally did not disclose additional data it discovered on the problem before submitting the drug for approval and failed to provide a scientific cause for the mix-up," the ministry said.

 A material used in Invossa came from a kidney cell instead of from cartilage as stated in the document submitted for approval by the drugmaker, according to the ministry.

 The regulatory body said in light of the seriousness of the matter, it has asked for a criminal investigation and will move to overhaul its drug review process to prevent a repeat of such incidents.

 

 

At present, there have been no cases of side effects associated with Invossa, but all people who have received treatment, will be closely monitored for upwards of 15 years.

 

A total of 438 hospitals and clinics have administered 3,707 shots of the drug so far.

 

Invossa is the world's first gene therapy drug for osteoarthritis, a movable joints disorder that affects many elderly people, with patient numbers in South Korea alone estimated to be around 5 million.

 

Distribution of the drug that received formal approval for sale in the domestic market in July 2017 has been suspended since April this year, with authorities conducting detailed on-site inspections of Kolong's production plants and research facilities in South Korea and the United States.

 Kolon TissueGene, the drugmaker's U.S. biopharma affiliate, produced the osteoarthritis treatment drug using a material that did not coincide with what was reported when tests on the drug began.

 The company earlier cited limitations in the early 2000s that caused it to not properly identify the materials used in the gene therapy drug.

 Before the incident, the drug was hailed as a feat for South Korea's biopharma business that had lagged behind foreign rivals.

 "Invossa was a pioneer in this field, with the cancellation likely to impact other projects, especially in the receiving of critical item permits from authorities," a market watcher said.

 Outside of Korea, Invossa has been sold in Hong Kong and Macau, with Kolon announcing in January that it reached an export deal to ship the drug to places like Singapore and Indonesia. It, moreover, signed a deal to ship the product to China last year.

 Related to the government decision, Kolon Group, the parent conglomerate of Kolon Life Science, did not release an official response although insiders said in private they were bewildered by the severity of the ruling and worried about the overall business repercussions.

 Patients who have used Invossa in the past and were moving to take legal actions against Kolon said the ministry did the right thing to safeguard public health.

 Oh Kims Law & Co., a law firm here, said initially 244 people are demanding compensation in a legal suit, with the complaint to be submitted to the Seoul Central District Court.

 "Kolon needs to be held accountable for hiding its mistakes that directly have a bearing on the health of users and for trying to dodge responsibility," the law firm said.

 It said such actions are fueling widespread anger among patients, and compensation in total is estimated at around 2.5 billion won (US$2.1 million) as of now, since a single shot of Invossa costs a patient 7 million won.

< 저작권자 © eseoulpost 무단전재 및 재배포금지 >
폰트키우기 폰트줄이기 프린트하기 메일보내기 신고하기
트위터 페이스북 미투데이 요즘 네이버 구글 msn 뒤로가기 위로가기
이 기사에 대한 댓글 이야기 (0)
자동등록방지용 코드를 입력하세요!   
확인
- 200자까지 쓰실 수 있습니다. (현재 0 byte / 최대 400byte)
- 욕설등 인신공격성 글은 삭제 합니다. [운영원칙]
이 기사에 대한 댓글 이야기 (0)
Most Read
1
UAE welcomes efforts to defuse tension, maintain stability in the region, says Abdullah bin Zayed
2
UAE to participate in Tan-Tan Moussem in Morocco
3
Sheikh Zayed Grand Mosque receives 17,2695 visitors during Eid al-Fitr
4
Medical Liability Law will strengthen health sector and reduce medical errors, says MoHAP
5
Op-Ed: UAE focuses on overcoming the impossible
6
Mohamed bin Zayed receives German FM
7
Mohamed bin Zayed, Chairman of Vista Equity Partners explore joint technological cooperation
8
Journalists in Nepal Discuss Media Responsibility for Global Peacebuilding
9
Sharjah Police Chief meets graduates of Sharjah Police Academy
10
Moon embarks on Northern Europe tour with focus on peace, innovative growth
Photo News Green Biz
World Green Economy Summit 2018 concludes
World Green Economy Summit 2018 co...
min
Restoration of nature requires actions of many :Al Zeyoudi
Restoration of nature requires act...
min
Al Zeyoudi to head UAE delegation to upcoming Global Climate Action Summit in California
Al Zeyoudi to head UAE delegation ...
min
Plastic wastes from Korea legal: MisOr ecozone exec
Plastic wastes from Korea legal: M...
min
Spotlight on UAE's environmental efforts at Urban Sustainability Week
Spotlight on UAE's environmental e...
min
Photo News Sports
Sharjah welcomes delegates of 24 countries participating in Special Olympics Abu Dhabi
Sharjah welcomes delegates of 24 c...
min
Mohammed bin Rashid attends 'UAE Tour'
Mohammed bin Rashid attends 'UAE T...
min
Koreas to field joint teams in 4 sports at 2020 Tokyo Olympics
Koreas to field joint teams in 4 s...
min
Over 500 Paralympic athletes to compete in IWAS World Games 2019 on Sunday in Sharjah
Over 500 Paralympic athletes to co...
min
New York City FC announces preseason in Abu Dhabi
New York City FC announces preseas...
min
AFC Asian Cup UAE 2019
AFC Asian Cup UAE 2019
min
VP crowns Abdullah Al Marri winner of Mohammed Bin Rashid Endurance Cup
VP crowns Abdullah Al Marri winner...
min
Welcome to the land of Zayed, land of tolerance, Nahyan bin Zayed tells 2019 AFC Asian Cup teams
Welcome to the land of Zayed, land...
min
Photo News World
Sharjah welcomes delegates of 24 countries participating in Special Olympics Abu Dhabi
Sharjah welcomes delegates of 24 c...
min
Mohammed bin Rashid attends 'UAE Tour'
Mohammed bin Rashid attends 'UAE T...
min
Koreas to field joint teams in 4 sports at 2020 Tokyo Olympics
Koreas to field joint teams in 4 s...
min
Over 500 Paralympic athletes to compete in IWAS World Games 2019 on Sunday in Sharjah
Over 500 Paralympic athletes to co...
min
New York City FC announces preseason in Abu Dhabi
New York City FC announces preseas...
min
AFC Asian Cup UAE 2019
AFC Asian Cup UAE 2019
min
VP crowns Abdullah Al Marri winner of Mohammed Bin Rashid Endurance Cup
VP crowns Abdullah Al Marri winner...
min
Welcome to the land of Zayed, land of tolerance, Nahyan bin Zayed tells 2019 AFC Asian Cup teams
Welcome to the land of Zayed, land...
min
Photo News Opinion
Hyundai Heavy shareholders OK split-up plan amid labor opposition
Hyundai Heavy shareholders OK spli...
min
Seoul revokes license for gene therapy drug Invossa
Seoul revokes license for gene the...
min
OECD cuts growth outlook for S. Korea's economy to 2.4 percent
OECD cuts growth outlook for S. Ko...
min
S. Korea's potential growth rate to drop to 2.5 pct through 2022: KERI
S. Korea's potential growth rate t...
min
Moon pledges gov't support for non-memory chip businesses
Moon pledges gov't support for non...
min
Shareholders reject reappointment of Korean Air chief
Shareholders reject reappointment ...
min
Yonhap files complaint against News1 over unlawful distribution of Rodong Sinmun content
Yonhap files complaint against New...
min
President Moon names 7 new ministers in Cabinet reshuffle
President Moon names 7 new ministe...
min
Newspaper AboutNews ReportAdvertiseComplaintsPrivacy PolicyJuvenile protectionRejection of E-mail Collection
Gangnam-gu, Teheran 52 street in Tehran Bldg, 616(Yeoksam-dong)  |  Main Phone: 02) 563-0604  |  Fax: 02) 538-5665
Chairman : jeong-woo Lee  |  Advisor : byung-il Min  |  Publisher: jae-mo Kah  |  Editors: il-hong Kim
Registration Number 1928 Seoul ah  |  eseoulpost.com / eseoulpost.net / Global Korea.,Ltd
Copyright © 2011 eseoulpost. All rights reserved. mail to jaemokah@daum.com , kih10kr@empas.com/ www.globalkorea.info
arabafrica.net / UAE Interract / Emirtes News Agency(WAM)/ http://wam.org.ae / www.uaeinteract.com